255 related articles for article (PubMed ID: 28900840)
1. Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.
Grabbert M; Grimm T; Buchner A; Kretschmer A; Apfelbeck M; Schulz G; Jokisch F; Schneevoigt BS; Stief CG; Karl A
Int Urol Nephrol; 2017 Dec; 49(12):2137-2142. PubMed ID: 28900840
[TBL] [Abstract][Full Text] [Related]
2. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
3. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
4. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
5. Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
Mistretta FA; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Cancer Epidemiol; 2019 Apr; 59():135-142. PubMed ID: 30771698
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
Yuan JB; Zu XB; Miao JG; Wang J; Chen MF; Qi L
BJU Int; 2013 Jul; 112(2):E87-91. PubMed ID: 23323729
[TBL] [Abstract][Full Text] [Related]
8. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
[TBL] [Abstract][Full Text] [Related]
9. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
May M; Herrmann E; Bolenz C; Brookman-May S; Tiemann A; Moritz R; Fritsche HM; Burger M; Trojan L; Michel MS; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Bastian PJ
Ann Surg Oncol; 2011 Jul; 18(7):2018-25. PubMed ID: 21246405
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
[TBL] [Abstract][Full Text] [Related]
11. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma.
Crozier J; Papa N; Perera M; Stewart M; Goad J; Sengupta S; Bolton D; Lawrentschuk N
Investig Clin Urol; 2017 Nov; 58(6):416-422. PubMed ID: 29124240
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
13. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
Bochner BH; Dalbagni G; Sjoberg DD; Silberstein J; Keren Paz GE; Donat SM; Coleman JA; Mathew S; Vickers A; Schnorr GC; Feuerstein MA; Rapkin B; Parra RO; Herr HW; Laudone VP
Eur Urol; 2015 Jun; 67(6):1042-1050. PubMed ID: 25496767
[TBL] [Abstract][Full Text] [Related]
14. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
Kim HS; Kwak C; Kim HH; Ku JH
Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
Moschini M; Afferi L; Gandaglia G; D'Andrea D; Zamboni S; Di Bona C; Mordasini L; Mattei A; Baumeister P; Martini A; Burgio G; Shariat SF; Sanchez-Salas R; Cathelineau X; Stabile A; Zaffuto E; Salonia A; Colombo R; Necchi A; Montorsi F; Briganti A; Gallina A
Eur Urol Focus; 2021 Sep; 7(5):1067-1074. PubMed ID: 33020030
[TBL] [Abstract][Full Text] [Related]
16. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
Sodagum L; Passarelli R; Pfail J; Patel HV; Chua K; Doppalapudi SK; Golombos D; Elsamra SE; Singer EA; Jang TL; Srivastava A; Ghodoussipour S
Urol Oncol; 2024 Jan; 42(1):21.e9-21.e20. PubMed ID: 37953186
[TBL] [Abstract][Full Text] [Related]
17. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
[TBL] [Abstract][Full Text] [Related]
18. Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
Tamalunas A; Buchner A; Kretschmer A; Jokisch F; Schulz G; Eismann L; Stief CG; Grimm T
Urol Int; 2020; 104(7-8):551-558. PubMed ID: 32114587
[TBL] [Abstract][Full Text] [Related]
19. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.
Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X
J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303
[TBL] [Abstract][Full Text] [Related]
20. Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution.
Tamalunas A; Volz Y; Schlenker BA; Buchner A; Kretschmer A; Jokisch F; Rodler S; Schulz G; Eismann L; Pfitzinger P; Stief CG; Grimm T
Urol Int; 2020; 104(11-12):975-981. PubMed ID: 32871580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
